| Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease A Bejanin, DR Schonhaut, R La Joie, JH Kramer, SL Baker, N Sosa, ... Brain 140 (12), 3286-3300, 2017 | 720 | 2017 |
| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 634 | 2020 |
| Four distinct trajectories of tau deposition identified in Alzheimer’s disease JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ... Nature Medicine 27 (5), 871-881, 2021 | 588 | 2021 |
| The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features R Ossenkoppele, YAL Pijnenburg, DC Perry, BI Cohn-Sheehy, ... Brain 138 (9), 2732-2749, 2015 | 583 | 2015 |
| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Science translational medicine 12 (524), eaau5732, 2020 | 508 | 2020 |
| Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease A Maass, S Landau, SL Baker, A Horng, SN Lockhart, R La Joie, ... Neuroimage 157, 448-463, 2017 | 446 | 2017 |
| Why musical memory can be preserved in advanced Alzheimer’s disease JH Jacobsen, J Stelzer, TH Fritz, G Chételat, R La Joie, R Turner Brain 138 (8), 2438-2450, 2015 | 437 | 2015 |
| Discriminative Accuracy of [18F] flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ... JAMA 320 (11), 1151-1162, 2018 | 420 | 2018 |
| Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation S Villeneuve, GD Rabinovici, BI Cohn-Sheehy, C Madison, N Ayakta, ... Brain 138 (7), 2020-2033, 2015 | 411 | 2015 |
| Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ... NeuroImage: Clinical 2, 356-365, 2013 | 411 | 2013 |
| Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia R La Joie, A Perrotin, L Barré, C Hommet, F Mézenge, M Ibazizene, ... Journal of Neuroscience 32 (46), 16265-16273, 2012 | 396 | 2012 |
| Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease R De Flores, R La Joie, G Chételat Neuroscience 309, 29-50, 2015 | 382 | 2015 |
| Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021 | 375 | 2021 |
| Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders EM Arenaza-Urquijo, B Landeau, R La Joie, K Mevel, F Mézenge, ... Neuroimage 83, 450-457, 2013 | 345 | 2013 |
| Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol PA Yushkevich, RSC Amaral, JC Augustinack, AR Bender, JD Bernstein, ... Neuroimage 111, 526-541, 2015 | 326 | 2015 |
| Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia R La Joie, A Perrotin, V De La Sayette, S Egret, L Doeuvre, S Belliard, ... NeuroImage: Clinical 3, 155-162, 2013 | 306 | 2013 |
| Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment V Camus, P Payoux, L Barré, B Desgranges, T Voisin, C Tauber, ... European journal of nuclear medicine and molecular imaging 39, 621-631, 2012 | 279 | 2012 |
| Longitudinal tau accumulation and atrophy in aging and alzheimer disease TM Harrison, R La Joie, A Maass, SL Baker, K Swinnerton, L Fenton, ... Annals of neurology 85 (2), 229-240, 2019 | 267 | 2019 |
| Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease R Ossenkoppele, BI Cohn‐Sheehy, R La Joie, JW Vogel, C Möller, ... Human brain mapping 36 (11), 4421-4437, 2015 | 254 | 2015 |
| Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021 | 228 | 2021 |
Gil RabinoviciZweryfikowany adres z ucsf.edu
